Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5530-5536

  Pioli, C ^a   Gatta, L ^a   Ubaldi, V ^a   Doria, G ^a  

^a ENEA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034669916     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5530     Document Type: Article

References (42)

1. CTLA-4 and T cell activation
2. Role of the CTLA-4 receptor in T cell activation and immunity: Physiologic function of the CTLA-4 receptor
3. CTLA-4 ligation blocks CD28-dependent T cell activation
4. CTLA-4-mediated inhibition of early events of T cell proliferation
5. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4
6. Enhancement of antitumor immunity by CTLA-4 blockade
7. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis
8. CTLA-4: A negative regulator of autoimmune disease
9. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival
10. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment
11. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
12. The role of CTLA-4 in the regulation and initiation of T-cell responses
13. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers: The Belgian Diabetes Registry
14. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
15. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
16. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
17. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
18. Activated T cells can induce high levels of CTLA-4 expression on B cells
19. In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas
20. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IκBα degradation and ReIA activation
21. Regulation of surface and intracellular expression of CTLA4 on mouse T cells
22. Requirement for dual signals by anti-CD40 and IL-4 for the induction of NF-κB, IL-6, and IgE in human B lymphocytes
23. Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: Evidence for successive class switching from μ to ε via γl
24. Antibody class switching
25. The immunoglobulin class switch: Beyond 'accessibility'
26. STAT6, NF-κB and C/EBP in CD23 expression and IgE production
27. Mechanism and regulation of immunoglobulin isotype switching
28. Activation of lymphocytes by BAT and anti CTLA-4: Comparison of binding to T and B cells
29. Activation and regulation of the IκB kinase in human B cells by CD40 signaling
30. Essential role of Stat6 in IL-4 signalling
31. Interaction of STAT6 and NF-κB: Direct association and synergistic activation of IL-4-induced transcription
32. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NFκB and is inhibited by protease inhibitors
33. The beginning of the end: IκB kinase (IKK) and NF-κB activation
34. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor ζ and ZAP70
35. Molecular basis of T cell inactivation by CTLA-4
36. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4
37. Activation of the IκBα kinase complex by MEKKI, a kinase of the JNK pathway
38. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAKI
39. The role of CTLA-4 in regulating Th2 differentiation
40. Protective immunity to nematode infection is induced by CTLA-4 blockade
41. Expression, regulation, and function of B cell-expressed CD154 in germinal centers